William Turner, CRNA | |
303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 | |
(352) 733-0485 | |
Not Available |
Full Name | William Turner |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 10 Years |
Location | 303 N Clyde Morris Blvd, Daytona Beach, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043610520 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 168728 (Tennessee) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | APRN9430694 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Halifax Health Medical Center | Daytona beach, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Clinical Practice Association | 0345146254 | 1636 |
News Archive
HealthSouth Corporation today announced it has signed an agreement to divest HealthSouth Rehabilitation of Baton Rouge, La., to Baton Rouge Rehabilitation Hospital, LLC. The divesture is expected to be completed on January 29, 2010.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Hospital marketing has reached a frenzy. It is nearly impossible to drive around metropolitan areas in the U.S. without being barraged by billboards trumpeting hospitals' cutting-edge technology, luxurious facilities, or the lives of patients they have saved.
Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.
› Verified 4 days ago
Entity Name | Sheridan Healthcorp Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
HealthSouth Corporation today announced it has signed an agreement to divest HealthSouth Rehabilitation of Baton Rouge, La., to Baton Rouge Rehabilitation Hospital, LLC. The divesture is expected to be completed on January 29, 2010.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Hospital marketing has reached a frenzy. It is nearly impossible to drive around metropolitan areas in the U.S. without being barraged by billboards trumpeting hospitals' cutting-edge technology, luxurious facilities, or the lives of patients they have saved.
Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.
› Verified 4 days ago
Entity Name | Florida Clinical Practice Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063463768 PECOS PAC ID: 0345146254 Enrollment ID: O20031211000099 |
News Archive
HealthSouth Corporation today announced it has signed an agreement to divest HealthSouth Rehabilitation of Baton Rouge, La., to Baton Rouge Rehabilitation Hospital, LLC. The divesture is expected to be completed on January 29, 2010.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Hospital marketing has reached a frenzy. It is nearly impossible to drive around metropolitan areas in the U.S. without being barraged by billboards trumpeting hospitals' cutting-edge technology, luxurious facilities, or the lives of patients they have saved.
Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
William Turner, CRNA 1329 Sw 16th St, Gainesville, FL 32608-1128 Ph: (352) 733-0485 | William Turner, CRNA 303 N Clyde Morris Blvd, Daytona Beach, FL 32114-2709 Ph: (352) 733-0485 |
News Archive
HealthSouth Corporation today announced it has signed an agreement to divest HealthSouth Rehabilitation of Baton Rouge, La., to Baton Rouge Rehabilitation Hospital, LLC. The divesture is expected to be completed on January 29, 2010.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan's 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.
Hospital marketing has reached a frenzy. It is nearly impossible to drive around metropolitan areas in the U.S. without being barraged by billboards trumpeting hospitals' cutting-edge technology, luxurious facilities, or the lives of patients they have saved.
Fear, trust, and the likelihood of exposure are three leading factors that influence whether people are willing to be vaccinated against a virulent disease, according to a new study in the journal Heliyon, published by Elsevier.
› Verified 4 days ago
Mr. J Patrick Kerr, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114 Phone: 386-255-1266 Fax: 386-255-8520 | |
Nicholas William Metakes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4000 | |
Mrs. Rosa Zamiris Perez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-3518 | |
Victoria Lynn Carr, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 301 Memorial Medical Pkwy, Daytona Beach, FL 32117 Phone: 386-231-4519 | |
Clayton T Saxour, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd, Suite 350, Daytona Beach, FL 32114 Phone: 386-255-1266 | |
Patricia Gonzalez, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 311 N Clyde Morris Blvd, Daytona Beach, FL 32114 Phone: 386-254-4000 |